HZ97ZZZ
HZ97ZZZ — Pharmacotherapy for Substance Abuse Treatment, Bupropion
Billable / specific codeICD-10-PCS
CMS abbreviated title: Pharmacotherapy for Substance Abuse Treatment, Bupropion
How HZ97ZZZ is built
Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.
- HSectionSubstance Abuse Treatment — What family of procedure this is
- ZBody systemWhich system it acts on
- 9Root operationThe objective — the verb of the procedure
- 7Body partThe specific site
- ZApproachHow the site was reached
- ZDeviceWhat was left in place, if anything
- ZQualifierA further distinction where one applies
Codes near HZ97ZZZ
In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.
- HZ90ZZZPharmacotherapy for Substance Abuse Treatment, Nicotine Replacement
- HZ91ZZZPharmacotherapy for Substance Abuse Treatment, Methadone Maintenance
- HZ92ZZZPharmacotherapy for Substance Abuse Treatment, Levo-alpha-acetyl-methadol (LAAM)
- HZ93ZZZPharmacotherapy for Substance Abuse Treatment, Antabuse
- HZ94ZZZPharmacotherapy for Substance Abuse Treatment, Naltrexone
- HZ95ZZZPharmacotherapy for Substance Abuse Treatment, Naloxone
- HZ96ZZZPharmacotherapy for Substance Abuse Treatment, Clonidine
- HZ97ZZZPharmacotherapy for Substance Abuse Treatment, Bupropion
- HZ98ZZZPharmacotherapy for Substance Abuse Treatment, Psychiatric Medication
- HZ99ZZZPharmacotherapy for Substance Abuse Treatment, Other Replacement Medication
- X051329Destruction of Renal Sympathetic Nerve(s) using Ultrasound Ablation, Percutaneous Approach, New Technology Group 9
- X05133ADestruction of Renal Sympathetic Nerve(s) using Radiofrequency Ablation, Percutaneous Approach, New Technology Group 10
- X05233BDestruction of Thoracic Sympathetic Nerve, Cardiac Plexus using Radiofrequency Ablation, Percutaneous Approach, New Technology Group 11
- X053X4BDestruction of Brain using Focused Ultrasound Therapy, External Approach, New Technology Group 11